查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1300958

心房顫動市場規模、份額和趨勢分析報告：按治療類型、最終用途、地區、細分市場趨勢：2023-2030

Atrial Fibrillation Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatment, Non-Pharmacological Treatment), By End-use (Hospital, Specialty Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10個工作天內

價格

心房顫動市場增長和趨勢

Grand View Research, Inc. 預計將繼續發布新報告。

根據美國國立衛生研究院的數據，心房顫動影響著全球 3750 萬人（佔人口的 0.51%），在過去 20 年中增加了 33%。

此外，由於心房顫動影響著全世界數百萬人，每年導致數千人住院和死亡，因此迫切需要創新的治療方法和解決方案。 僅在美國，CDC 報告每年就有近 454,000 例因心房顫動住院治療和超過 158,000 例死亡。 這些數字對於開發和營銷用於房顫診斷、治療和管理的新產品的公司來說代表著巨大的市場機會。

儘管心房顫動通常在急診科接受治療，但與大流行前相比，在 COVID-19 大流行期間因心房顫動初步診斷而住院的人數有所減少。我來了。 儘管如此，MDPI在2021年發表的一篇論文發現，高達7.5%的COVID-19患者可能會出現房顫，增加了房顫治療的需求，我認為有可能。 然而，其他研究表明，患者行為的改變、房顫治療的下降以及全球供應鏈中斷導致某些醫療器械和器械短缺，導致了大流行期間出現持續性、陣發性房顫。痢疾患者就診的次數減少。

政府批准的增加和主要參與者新產品的推出預計將推動心房顫動產品市場的增長。 例如，2023 年 3 月，美敦力的消融系統和 Affera Mapping 獲得了 CE 標誌批准，用於通過 Affera Prism-1 Mapping 軟件和 Sphere-9 導管治療房性心律失常。 該系統集射頻消融、脈衝場消融和高密度標測導管於一體，可實時反饋異常心律並提供精確的標測和消融，樹立了電生理學的新標準。

心房顫動市場報告亮點

  • 根據治療類型，心房顫動市場分為藥物治療和非藥物治療。 由於抗凝劑和抗心律失常藥物的高需求，2022 年藥物治療領域在心房顫動市場中佔據最大收入份額，超過 65%。
  • 根據最終用途，市場進一步細分為醫院、專科診所等。 預計到 2022 年，醫院領域將佔據最大的市場份額，預測期內復合年增長率最快，達到 10.4%。 該細分市場的快速增長主要是由於醫院進行的手術數量較多。
  • 由於心房顫動的患病率和患病率不斷增加，預計到 2022 年，北美將主導市場並佔據最大收入份額，超過 39%。
  • 由於近年來醫療基礎設施投資增加，預計亞太地區將以最快的速度增長，特別是在中國和印度等新興經濟體。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 市場定義
  • 信息獲取
    • 購買的數據庫
    • GVR 內部數據庫
    • 二手信息和第三方觀點
    • 初步調查
    • 初步調查的詳細信息
  • 信息分析
    • 數據分析模型
  • 市場形成和數據可視化
    • 產品流分析
  • 驗證和發布數據
  • 全球市場：計算複合年增長率
  • 輔助信息列表
  • 主要信息列表

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第三章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場趨勢和展望
  • 市場動態
  • 市場製約因素分析
  • 商業環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
  • COVID-19 感染的影響分析

第 4 章治療類型的業務分析

  • 心房顫動市場（按治療類型）：主要要點
  • 心房顫動市場：2022 年和 2030 年治療類型趨勢和市場份額分析
  • 藥物治療
    • 2018 年至 2030 年世界藥物治療市場估計和預測
    • 抗心律失常藥物
    • 抗凝劑
  • 非藥物治療
    • 2018-2030 年世界非藥物治療市場估計和預測
    • 導管消融
    • 迷宮手術
    • 心臟復律

第 5 章最終用途業務分析

  • 心房顫動市場，按最終用途：主要要點
  • 心房顫動市場：2022 年和 2030 年最終用途變化和市場份額分析
  • 醫院
    • 2018-2030 年全球醫院市場估算和預測
  • 專科診所
    • 2018-2030 年全球專科診所市場估算和預測
  • 其他
    • 2018-2030 年其他全球市場預估和預測

第 6 章區域業務分析

  • 區域市場快照
  • 2022 年按地區劃分的市場份額分析
  • 北美
    • 2018-2030 年北美房顫市場
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲心房顫動市場
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區心房顫動市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲心房顫動市場
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 2018-2030 年中東和非洲心房顫動市場
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第7章競爭格局

  • 公司分類
  • 戰略規劃
  • 公司簡介列表
    • AtriCure Inc.
    • Boehringer Ingelheim GmbH
    • Boston Scientific Corporation.
    • Bristol-Myers Squibb Corporation
    • Cardio Focus Inc.
    • Sanofi Aventis
    • Biosense Webster Inc.
    • Endoscopic Technologies Inc.
    • Abbott（St. Jude Medical Inc.）
    • Johnsons &Johnson
Product Code: 978-1-68038-004-0

Atrial Fibrillation Market Growth & Trends

The global atrial fibrillation market size is expected to reach USD 48.01 billion by 2030, registering at a CAGR of 10.1%, according to a new report by Grand View Research, Inc.Aging population, lifestyle changes, and chronic diseases such as diabetes and obesity are factors contributing to the increasing incidence of atrial fibrillation (AFib). The National Institute of Health reports that AFib affects 37.5 million people globally (0.51% of the population), a 33% increase in the past 20 years.

Moreover, with millions worldwide affected by AFib, and thousands of hospitalizations and deaths annually, there is a critical need for innovative therapies and solutions. In the U.S. alone, the CDC reports almost 454,000 hospitalizations with AFib as the primary diagnosis each year, resulting in over 158,000 deaths. These numbers highlight a significant market opportunity for companies to develop and market new products for diagnosing, treating, and managing atrial fibrillation.

Atrial fibrillation is commonly treated in emergency departments, but during the COVID-19 pandemic, there has been a decrease in admissions for primary diagnoses of AF compared to pre-pandemic times. Despite this, the article published by MDPI in 2021 states that up to 7.5% of COVID-19 patients may develop AF, which could increase the demand for AF treatments. However, other studies have reported a decrease in visits by patients with persistent and paroxysmal atrial fibrillation during the pandemic, due to changes in patient behavior, a decline in AF procedures, and disruptions to global supply chains causing shortages of certain medical devices and equipment.

Increasing government approvals and new product launches by key players are expected to drive growth in the atrial fibrillation products market. For instance, in March 2023, Medtronic received CE Mark approval for its Ablation System and Affera Mapping, which is designed to treat atrial arrhythmias using the Affera Prism-1 Mapping Software and Sphere-9 Catheter. This system integrates radiofrequency, pulsed field ablation, and high-density mapping catheter to provide real-time feedback and accurate mapping and ablation of abnormal heart rhythms, creating a new standard in electrophysiology.

Atrial Fibrillation Market Report Highlights

  • Based on treatment type, the AFib market is segmented into pharmacological and non-pharmacological treatment. Pharmacological treatment segment held the largest revenue share of over 65% of the atrial fibrillation market in 2022, due to the high demand for anticoagulant drugs and anti-arrhythmic drugs
  • Based on end-use, the market has been further categorized into hospitals, specialty clinics, and others. The hospitals segment accounted for the largest share of the market in 2022, and it is estimated to register the fastest CAGR of 10.4% during the forecast period. The segment's rapid growth is primarily attributed to the high number of surgeries performed in hospitals
  • The North American region is expected to dominate the market and held the largest revenue share of over 39% in 2022, owing to the increasing incidence of atrial fibrillation and a large patient population
  • Asia Pacific is estimated to grow at the fastest rate during the forecast period due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Treatment Type Business Analysis

  • 4.1. Atrial Fibrillation Market, By Treatment Type: Key Takeaways
  • 4.2. Atrial Fibrillation Market: Treatment Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Pharmacological Treatment
    • 4.3.1. Global Pharmacological Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Anti-arrhythmic Drugs
      • 4.3.2.1. Global Anti-arrhythmic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Anticoagulant Drugs
      • 4.3.3.1. Global Anticoagulant Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Non-Pharmacological Treatment
    • 4.4.1. Global Non-Pharmacological Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Catheter Ablation
      • 4.4.2.1. Global Catheter Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Radiofrequency
      • 4.4.2.2.1. Global Radiofrequency Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. HIFU
      • 4.4.2.3.1. Global HIFU Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.4. Cryoablation
      • 4.4.2.4.1. Global Cryoablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.5. Microwave
      • 4.4.2.5.1. Global Microwave Market Estimates and Forecasts, 2018 - 2030 (USD Million
      • 4.4.2.6. Laser
      • 4.4.2.6.1. Global Laser Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Maze Surgery
      • 4.4.3.1. Global Maze Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Electric Cardioversion
      • 4.4.4.1. Global Electric Cardioversion Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Atrial Fibrillation Market, By End-Use: Key Takeaways
  • 5.2. Atrial Fibrillation Market: End-Use Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Specialty Clinics
    • 5.4.1. Global Specialty Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. Market Share Analysis by Region, 2022
  • 6.3. North America
    • 6.3.1. North America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Germany Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.3. UK
      • 6.4.3.1. UK Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. France Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Denmark Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Sweden Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Norway Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. China Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. India Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. South Korea Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Australia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Thailand Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. South Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Saudi Arabia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait Atrial Fibrillation Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Profiles/Listing
    • 7.3.1. AtriCure Inc.
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Boehringer Ingelheim GmbH
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Boston Scientific Corporation.
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Bristol- Myers Squibb Corporation
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Cardio Focus Inc.
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Sanofi Aventis
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Biosense Webster Inc.
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Endoscopic Technologies Inc.
      • 7.3.8.1. Overview
      • 7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Abbott (St. Jude Medical Inc.)
      • 7.3.9.1. Overview
      • 7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Johnsons & Johnson
      • 7.3.10.1. Overview
      • 7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 3 Global Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global Atrial Fibrillation Market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 7 North America Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 11 Canada Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 14 Europe Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 16 Germany Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 18 UK Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 20 France Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 22 Italy Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 24 Spain Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 26 Denmark Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 28 Sweden Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 30 Norway Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 China Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 35 China Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 37 Japan Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 India Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 39 India Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 41 South Korea Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 43 Australia Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 45 Thailand Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 48 Latin America Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 50 Brazil Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 52 Mexico Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 54 Argentina Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 South Africa Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 58 South Africa Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 UAE Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 62 UAE Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Atrial Fibrillation Market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2022
  • Fig. 15 Global Atrial Fibrillation Market: treatment type outlook key takeaways
  • Fig. 16 Global Atrial Fibrillation Market: treatment type movement analysis
  • Fig. 17 Pharmacological Treatment market, 2018 - 2030 (USD Million)
  • Fig. 18 Anti-arrhythmic Drugs market, 2018 - 2030 (USD Million)
  • Fig. 19 Anticoagulant Drugs market, 2018 - 2030 (USD Million)
  • Fig. 20 Non-Pharmacological Treatment market, 2018 - 2030 (USD Million)
  • Fig. 21 Catheter Ablation market, 2018 - 2030 (USD Million)
  • Fig. 22 Radiofrequency market, 2018 - 2030 (USD Million)
  • Fig. 23 HIFU market, 2018 - 2030 (USD Million)
  • Fig. 24 Cryoablation market, 2018 - 2030 (USD Million)
  • Fig. 25 Microwave market, 2018 - 2030 (USD Million)
  • Fig. 26 Laser market, 2018 - 2030 (USD Million)
  • Fig. 27 Maze Surgery market, 2018 - 2030 (USD Million)
  • Fig. 28 Electric Cardioversion market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Atrial Fibrillation Market: end-use outlook key takeaways
  • Fig. 30 Global Atrial Fibrillation Market: end-use movement analysis
  • Fig. 31 Global Hospital market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Specialty Clinics market, 2018 - 2030 (USD Million)
  • Fig. 33 Global others market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional marketplace: key takeaways
  • Fig. 35 Regional outlook, 2022 & 2030
  • Fig. 36 Global Atrial Fibrillation Market: region movement analysis
  • Fig. 37 North America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia pacific Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 58 Mexico Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 60 Middle East and Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 63 UAE Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait Atrial Fibrillation Market, 2018 - 2030 (USD Million)